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ABSTRACT
The many advances in scientific and engineer­ 
ing knowledge produced by NASA space research 
often apply to major problems of modern soci­ 
ety. To assist in the application of new tech­ 
nology and thus reduce the time interval from 
space development to direct benefit to society, 
NASA had established a technology-application 
effort at the Goddard Space Flight Center. As 
part of this effort we have been using, in col­ 
laboration with GSFC and also independently, 
technology for the detection of extraterres­ 
trial life to develop a simple, fast and ac­ 
curate procedure for detecting and counting 
bacteria in clinical specimens since manage­ 
ment of infectious disease continues to be 
dependent upon primary isolation and cultur- 
ing of organisms infecting biological fluids.
The medical applications of luminescent systems 
are a direct outgrowth of technology-applica­ 
tion effort. The firefly luciferase assay for 
adenosine triphosphate (ATP) was a candidate 
for remote detection of microbes on other 
planets, such as Mars, as ATP is found in all 
living organisms on earth. An indication of 
the presence of ATP on another planet would 
suggest the existance of extraterrestrial life 
forms similar to those we know. Thus, ubiqui­ 
tous distribution of ATP make precise, quanti­ 
tative measurement of this compound a particu­ 
larly promising chemical method for rapid de­ 
tecting and quantitating microorganisms and 
for the study of cellular integrity and 
changes associated with various pathological 
processes, monitoring of inflammatory diseases, 
and sensitive determination of homograft via­ 
bility. Recently this method is being adopted 
for rapid determination of metabolic integri­ 
ty and viability of leprosy bacillus, since 
this organism has not yet been grown outside 
of its natural host and there is no suitable 
animal model currently available that can be 
used in endemic areas of the world. Thus, in­ 
vestigations undertaken in the 1960's by the
GSFC has given a hope of major breakthrough to 
control leprosy which has so far inflicted 15 
million of the world population.
INTRODUCTION
Among the vast array of questions to which man 
is seeking answers in his investigations of 
the upper atmosphere and outer space, there is 
none more challenging and provocative than 
that pertaining to the existence of life out­ 
side terrestrial boundries. Basic to these 
studies is the establishment of the parameters 
which define life. A definition which is ame­ 
nable to operational manipulation is one which 
characterizes life as the capicity of a molec­ 
ular complex to perform certain functional ac­ 
tivities including metabolism, growth and re­ 
production. The detection of life in many in­ 
stances is not a difficult matter, especially 
when there are visible manifestations such as 
characteristic form, movement and reproduction. 
This, however, becomes increasingly difficult 
as the size of the organism becomes microscop­ 
ic, and even more so as the number of organ­ 
isms being sampled decreases. It is at this 
point that the classical life detection tech­ 
niques begin to be dependent upon one of the 
manifestations mentioned above; namely, repro­ 
duction.
All terrestrial life insofar as is presently 
known, Is intimately associated with, and de­ 
pendent upon, the nucleotide phosphate, adeno- 
sinetriphosphate (ATP). The ubiquity of this 
compound in living organisms renders it an ex­ 
cellent indicator of the presence or absence 
of life. Furthermore, changes in the meta­ 
bolic integrity of a living organism are fre­ 
quently accompanied by variations in the 
steady state concentration of ATP in the or­ 
ganism. Thus, not only may ATP measurements 
provide the basis for the detection of life, 
but may also be exploited for the detection of 
metabolic changes, both normal and
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pathological. In order to realize the full 
potential of ATP as a monitor for the pres­ 
ence of life in space, it was necessary to 
select and develop a method with which it 
could be assayed with the highest degree of 
sensitivity, accuracy, and rapidity.
METHODOLOGY
The many advances in scientific and engineer­ 
ing knowledge produced by NASA space research 
often apply to major problems of modern soci­ 
ety. To assist in the application of new 
technology and thus reduce the time interval 
from space development to direct benefit to 
society, NASA had established a technology- 
application effort at Goddard Space Flight 
Center, Maryland. As part of this effort, we 
have been using, in collaboration with scien­ 
tists at GSFC and also independently, technol­ 
ogy for the detection of extraterrestrial life 
to develop a simple, fast and accurate proce­ 
dure for detecting and counting bacteria in 
clinical specimens, since management of infec­ 
tious diseases continues to be dependent upon 
primary isolation and culturing of organisms 
infecting biological fluids.
The most sensitive method available for meas­ 
uring ATP is based on the bioluminescent reac­ 
tion of 1uciferase when mixed with ATP, the 
reaction which also creates the glow in the 
tail of a firefly. The reaction is described 
in figure 1. The maximum intensity of emitted 
light in this reaction has a direct linear re­ 
lationship to the concentration of ATP added. 
This relationship exists over a range deter­ 
mined by a ratio of the concentration of lu- 
ciferin-1uciferase to that of ATP and by the 
sensitivity of the light measuring instru­ 
ments.
Figure 2 is a schematic drawing of the light- 
measuring instrumentation used in the ATP as­ 
say. This was designed and fabricated by the 
scientists at the GSFC, Maryland, in the late 
1960's, even though today several models are 
available commercially. It consists of a re­ 
action chamber, photomultiplier assembly, am­ 
plifier, power supply, and recorder. The re­ 
action chamber which is coupled to a photomul­ 
tiplier, is a rotary drum designed so that ac­ 
cess to and removal of the reaction cuvette is 
possible without exposing the photomultiplier 
to ambient light. The chamber can accomodate 
a 6 X 50 mm cuvette. Immediately above the 
cuvette holder, when rotated to the injection 
position, is a 0.040 inch injection port seal­ 
ed by a replaceable, light-tight, rubber dia­ 
phragm to eliminate light leaks during injec­ 
tion. All surfaces of the reaction chamber 
assembly, exclusive of the mirror, are painted 
optic black.
Microbiology has remained a traditional sci­ 
ence. One reason is that its tools and tech­ 
niques are, fundamentally, those developed 
years ago by Koch, Pasteur, and Gram. Today's 
common methods for estimating total numbers of 
microorganisms include direct microscopic 
counting, colony counting in cultures, meas­ 
urement of culture turbidity, weighing of 
cells and electronic particle counting. Each 
of these methods has inherent sources of error 
that have been tolerated and often ignored by 
those who use the methods. In an effort to 
overcome the limitations of physical cell size 
and culture techniques on the basis of bacte­ 
ria counting, investigators have explored, 
rather successfully, the feasibility of relat­ 
ing cell population to a single biochemical 
parameter of the individual cell,, and that pa­ 
rameter is ATP.
RESULTS
In the United States, where the incidence of 
urinary-tract infection is second only to that 
of respiratory-system infection, the examina­ 
tion of urine for bacteria is one of the most 
frequent and important clinical assays. Nor­ 
mally therapy is instituted only 48 - 72 
hours after a specimen is collected and pro­ 
cessed in the laboratory. Obtaining quick 
and reliable answers to such questions as, "Is 
an organism present?", "How many are present?" 
and "What is the antibiotic of choice for 
treatment?" would lead to a more rational ap­ 
proach to therapy. Using ATP measurements, 
the early detection of a significant bacter- 
iuria coupled with a direct antimicrobial sus­ 
ceptibility determination offers the potential 
for initiation of therapy within 4-6 hours 
after a clinical specimen is received in the 
microbiology laboratory.
With this in mind, a comparison of the ATP 
assay to other commonly used methods of urine 
examination was made. Data in figure 3 show 
that when a colony count showed that specimens 
had 10,000 colonies per ml or more, an ATP as­ 
say of the same specimens showed positive re­ 
sults. About 20 percent of the urine speci­ 
mens with a negative culture-colony count 
showed positive ATP results.
To assess how results from the ATP assay cor­ 
related to results from a culture-colony 
count, the average ATP content of a bacteria 
cell was determined. As shown in figure 4, in 
an ATP assay of the nine bacterial species 
commonly found in urine, the ATP content per 
cell ranged from 0.5 to 8.2 X 10' 10 ugm. The 
value used for this conversion of ATP concen­ 
tration into cells per ml was 3 X 10" 10 ygm.
Results from selected urine specimens were 
used to determine a relationship between the
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number of bacteria found by culture-colony 
count and the number of bacteria calculated 
from the ATP response and they are presented 
in figure 5. The ATP assay revealed bacteria 
in so many more specimens than the culture- 
colony count did that results from the cul­ 
ture-colony count were compared to results 
from the more accurate pour plate technique. 
Although the pour plate procedure revealed 
more bacterial cells than the culture-colony 
method did, the results were still much lower 
than those from ATP measurements.
Another potential clinical application of the 
ATP assay is the direct antimicrobial suscep­ 
tibility testing of organisms found in urine. 
A typical result of this is shown in figure 6. 
A control containing organism but no antibiotic 
is represented by a solid line, and an organism 
grown in the presence of an antimicrobial agent 
is represented by the broken line. Ao is the 
ATP content of the growth control at zero time 
and Aj. is the ATP content of the control cul­ 
ture after 3 hours incubation. Thus, the ATP 
index is a ratio of the change in ATP in the 
presence of an antibiotic to the change in ATP 
in the control. An empirical cut-off of 0.05 
has been found to give good agreement with the 
results obtained by standard method (taking 72- 
96 hours). That is, an index of greater than 
0.05 is indicative of resistance and one of 
less than or equal to 0.05 is indicative of 
susceptibility to the antimicrobial agent. 
From this one can really appreciate the impor­ 
tance of ATP assay.
This procedure has also been tried with blood 
and other body fluids in several pathological 
problems and the results have been equally suc­ 
cessful .
What are the other practical applications of 
ATP assays? Three to five percent of swine on 
their way to market die of a condition called 
"porcine stress syndrome", which results in an 
annual loss to producers of $200 - $300 mil­ 
lions. One of 9,000 surgical patients under 
general anesthesia suddenly develop extremely 
high body temperature, severe metabolic acido- 
sis, muscle rigidity, hyperalkemia, and cardi­ 
ovascular collapse. The condition called "ma­ 
lignant hyperthermia", has been characterized 
as the "only" disease of the anesthesiologist, 
and is the major cause of unexpected death in 
anesthesia. With 15 million surgeries each 
year in the U.S. alone, one can expect at 
least 1,000 malignant hyperthermia victims 
with malpractice claims of $50,000 to $500,000 
each, since malignant hyperthermia is preven­ 
table. Duchenne muscular dystrophy (DMD) oc­ 
curs in about 1 of 3,000 male infants. No 
cure has been found, and the death usually oc­ 
curs before age 25. These three seemingly 
different and unrelated problems have some­ 
thing in common: they are all associated with
defective muscle ("myopathy") and resultant 
elevation of blood creatine phosphokinase 
(CPK). The methods currently available are 
either complicated or expensive for routine 
screening. However, ATP assay has given a new 
light. This assay can be used for routine 
screening even on newborn infants since it is 
simple, cheap, easy to perform, and oversen­ 
sitive. The principle of this is described in 
figure 7.
Leprosy is a chronic infectious disease caused 
by an organism called Mycobacterium leprae, 
which resembles in morphology and staining, to 
tubercle bacillus causing tuberculosis. Lep­ 
rosy affects approximately 15 million people 
in the world, and Asia, Africa and South Amer­ 
ica have the greatest number of reported 
cases. This number is increasing alarmingly 
and because of the rapidly developing resis­ 
tance to drugs, it is predicted that if the 
present trend continues, the number of cases 
in the world will double within a quarter of a 
century. It is easy to understand the tremen­ 
dous economic burden leprosy represents to de­ 
veloping countries, and indirectly to affluent 
societies. Only science and technology can 
solve the problem of leprosy.
Even though this organism was discovered in 
1873, it has not yet been propogated in arti­ 
ficial media, and this has become a real bot­ 
tleneck in leprosy research, especially in 
developing new drugs and vaccine. In the 
absence of in vitro growth the only method a- 
vailable to quantitate its biomass is micro­ 
scopic; however, this method does not distin­ 
guish between living and dead organisms. We 
have been using Mycobacterium lepraemurium, 
causative agent of rat leprosy, as an interim 
model of M_. leprae and we used ATP as a bio­ 
chemical indicator to study the physiology and 
growth of this organism. Figure 8 demonstra­ 
tes the utility of ATP data in such studies. 
M.- lepraemurium were obtained from rat livers 
and transferred to in vitro environments with 
various nutrients. If the external environ­ 
ment is suitable for these organisms to grow 
then the traditional microscopic method is ad­ 
equate to evaluate the growth (see curve B), 
and the same results will also be obtained 
using ATP assays (curve C). However, if the 
external environment is detrimental or neutral 
to the organisms, the mircroscopic method will 
not be able to distinguish between the two and 
data will be represented by curve A in either 
case. On the other hand, ATP assay technique 
can differentiate between the two processes. 
If it is harmless, it will be represented by 
curve A, while if the environment is detrimen­ 
tal to the organisms, the outcome will be 
curve D or E, depending on the degree of harm- 
fulness of the environment. Thus, ATP is 
being used as a useful tool to study these or­ 
ganisms. But how is it directly helping the 
leprosy patients in endemic areas?
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The only choice of drug presently available in 
endemic areas is 4,4'-diamino-diphenyl sulfone 
or Dapsone. But like any other disease-caus­ 
ing agents, the leprosy organisms are rapidly 
becoming resistant to dapsone, and thus, is 
becoming a serious problem in the eradication 
of this disease. Since children are more sus­ 
ceptible to contract the disease, the immedi­ 
ate danger is that a patient with dapsone- 
resistant leprosy organisms will transmit the 
disease to family contacts and there will be 
no readily available drug to treat these con­ 
tacts. The only method presently available to 
detect the drug-resistant leprosy cases is the 
mouse foot pad technique. This is time con­ 
suming (takes 9-12 months to obtain valid in­ 
formation) and very expensive to use in endem­ 
ic areas. Therefore, we have decided to use 
ATP assays for this purpose. Since, as men­ 
tioned above, this compound is ubiquitous in 
all living material, it will serve to deter­ 
mine the viability of leprosy organisms in pa­ 
tients under therapy and thus the susceptibil­ 
ity of these organisms to the given drug. The 
work in this direction is being initiated in 
collaboration with leprosy institutions from 
Argentina, Brazil, India and Surinam. The in­ 
terpretation is simple and is demonstrated in 
figure 9. In short, intracellular ATP of M. 
leprae from a given specimen before initiating 
treatment will be determined, and simultane­ 
ously microscopic counts will be made on the 
same material. Next, ATP per one million mic­ 
roscopically counted ML leprae cells will be 
calculated. This procedure will be repeated 
at intervals during the course of treatment. 
If ATP per aliquot (per one million M_. leprae 
cells) decreases during treatment, it will be 
interpreted as a positive response to the 
treatment since the drug therapy has inhibited 
biosynthetic capability of M_. leprae cells and 
their ability to grow and multiply, and thus 
rendered them non-viable. On the other hand, 
if ATP per aliquot remains steady or increases 
over original level, the conclusion will be 
that the treatment had no effect in inhibiting 
the matabolism of ML leprae and thus are still 
able to grow and multiply in the host.
Thus, you can now appreciate well that the 
investigations undertaken by NASA has given a 
hope of a major breakthrough to control this 
most dreadful disease on the earth.
Besides these clinical applications of ATP as­ 
say, this technique is being used in other 
fields also that are equally important in our 
day-to-day life and these are described here 
briefly.
First is the industrial application for bio- 
cide control in oil production. Large volumes 
of water are used to aid secondary recovery of 
oil. Natural water, water recovered from pro­ 
duced oil, and well waters are the primary
subjects for this use. Growth of microorgan­ 
isms in these systems through such deleteri­ 
ous effects as corrosion and by-products can 
quickly create conditions whereby the water 
can no longer be injected into the ground, 
which will result in a complete shutdown of an 
entire oil field. Most of these systems are 
pressurized (1,000 - 3,000 lb/in 2 ) and the 
troublesome organisms are difficult to culture 
under laboratory conditions and require at 
least 28 days incubation. The ATP assay tech­ 
nique is now widely used in this area to de­ 
tect the microorganisms and develop the micro- 
biocides for use in oil field waters.
This assay is also used as a rapid method for 
measuring the efficiency of disinfection of 
wastewater for purposes of regulating the ad­ 
dition of disinfectants. It is shown that 
decreases in ATP concentration in combined 
sewer overflows treated with chlorine and 
chlorine dioxide parallel decreases in the 
traditional indicators of disinfection, total 
and fecal coliform bacteria.
The ATP assay is also used to monitor the 
quality of potable water supply by way of enu­ 
merating planktonic biomass before and after 
treatment in a direct filtration water treat­ 
ment plant. The routine microscopic counting 
of plankton is very tedious and involves large 
operator errors.
Similar applications of ATP assay technique 
are being used in environmental studies where 
the determinations of microbial levels are 
involved.
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FIGURE 1. Firefly bioluminescent reaction for ATP,
Mq++ 
E + LH 2 + ATP —-——> E • LH 2 • AMP + PP
E • LH2 • AMP + 02—————>E + AMP + C02 + hv + T
E = firefly luciferase; 
LH2 = reduced luciferin; 
AMP = adenosine monophosphate; 
PP = pyrophosphate; 
T = thiazolinone (dehydroluciferin); 
hv = Tight (550 nm)
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Figure 2. A Schematic Drawing of the Instrumentation 
Used for the Light Measurements.
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FIGURE 3. Comparison between culture-colony 
counting and ATP assay.
No. of specimens 
tested
No. of colonies 
counted
No. of + ve ATP
responses
282
0
60
78
1 to 
10,000
42
39
10,000 to 
100,000
39
57
over 
100,000
57
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FIGURE 4. ATP content in bacteria.
Species ygm ATP/cell 
____ (X 1
Escherichia coli 1.2
Streptococcus faecal is 1.1
Staphyiococcus aureus 1.8 
Staphyiococcus epidermidis 8.2
Proteus mirabilis 4.3
Klebsiella 2.8
Pseudomonas 0.5
Proteus rettgeri 1.4
3 streptococcus 1.5
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FIGURE 5. Number of bacteria per ml urine sample 
determined by ATP assay, culture-colony 
plate, and pour plate.
Sample No.
1
2
3
4
5
6
7
ATP method
7 X 108
4 X 107
3 X 107
3 X 107
5 X 109
3 X TO7
8 X 107
Culture-colony plate
0
1 X 104
1 X 104
0
2 X 104
0
0
Pour plate
1 X 104
1 X 107
2 X 107
0
3 X 105
0
0
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FIGURE 6.
ATP ASSAY IN ANTIMICROBIAL 
SUSCEPTIBILITY TESTING
8-
to 
CO
Control 
+ Cephalothin
v<> ___——• Gentamicin
TIME (hrs)
FIGURE 7. Creatine Phosphokinase (CPK) reaction.
Creatine phosphate + ADP—————^Creatine + ATP 
ATP + Luciferin + 02 Luc^^ase > AMP + PP + Dehydroluciferin + Light.
8-40
FIGURE 8
03
SUPERIORITY OF ATP ASSAYS 
OVER MICROSCOPIC METHOD 
IN LEPROSY RESEARCH
WEEKS
LU 
O
Q_ 
<C
200..
FIGURE 9
INTERPRETATION OF ATP DATA IN 
PROGNOSIS OF LEPROSY PATIENTS 
UNDER THERAPY
o: 
o
100^.. ••«• R
1 2 3 
TREATMENT (MONTHS)
